AIDS News and Research

RSS

Sound masking therapy is of uncertain benefit when used alone to treat tinnitus

Tinnitus — what many think of as "ringing in the ears" — is the perception of sound without any real acoustic stimulation. Sound masking therapy, a common component of tinnitus treatment, is of uncertain benefit when used on its own, a new evidence review finds.

10 Dec 2010

WFP, UNAIDS work to improve nutritional support available for people living with HIV/AIDS

The World Program Program (WFP), with the support of UNAIDS, is planning to launch "a new policy to make food and nutritional support more available to people living with HIV," VOA News reports. The agency "says the aim of [the] program is to help patients stick to their treatment, while protecting their households from further vulnerability," the news service adds.

10 Dec 2010

Opinions: Questioning WHO's relevance; Reforming foreign aid; Efforts to prevent child marriage

"The WHO - for 62 years the world's go-to agency on all public health matters - is today outmoded, underfunded, and overly politicized," Jack Chow, former assistant director-general on HIV/AIDS, tuberculosis and malaria at WHO, writes in a Foreign Policy Argument where he outlines some of the major issues facing the WHO, including personnel challenges, the agency's "archaic" governance system and a "new atmosphere, where [other] organizations are taking health into their own hands."

10 Dec 2010

Genetic Immunity to present DermaVir and DermaPrep transdermal delivery system at HIV DART 2010 conference

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine vaccines, will present data at this week's HIV DART 2010 conference, "Frontiers in Drug Development for Antiretroviral Therapies," in Los Cabos, Mexico. The conference brings international researchers together to discuss the latest developments in the fight against HIV/AIDS.

9 Dec 2010

USAID, PEPFAR and HHS welcome WHO's endorsement of rapid diagnostic test for TB

The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).

9 Dec 2010

Rapid TB test endorsed by WHO

The World Health Organization (WHO) said that a new test that can detect tuberculosis (TB), including drug-resistant forms, in less than two hours could revolutionize treatment of the disease. Tuberculosis is still a major killer worldwide killing 4,700 people every day last year. The annual death toll of 1.7 million includes 380,000 people who are at particular risk because they have HIV, the virus that depresses the immune system and causes Aids.

8 Dec 2010

Vaccine World Summit to be held in New Delhi 1-3 March, 2011

From the 1st to the 3rd of March 2011, vaccine leaders from developing and developed world will meet at Vaccine World Summit in New Delhi. The event will be hosted by IMAPAC, in partnership with DCVMN (Developing Countries Vaccine Manufacturers Network).

8 Dec 2010

European Commission must stop attacking generic medicines, says ITPC

On International Human Rights Day, as the European Commission (EC) and the Government of India meet in Brussels to finalise a European Union (EU)-India free trade agreement, the International Treatment Preparedness Coalition (ITPC) calls on Indian negotiators to put the right to health of its citizens and of the fifteen million HIV-positive people worldwide needing treatment above the pharmaceutical companies' interests and profits.

8 Dec 2010

Matrix's NDA for Abacavir Sulfate receives tentative FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Abacavir Sulfate Tablets, 60 mg. The NDA is based on the reference listed drug Ziagen® by ViiV Healthcare.

7 Dec 2010

Breast cancer patients taking tamoxifen anxious to have CYP2D6 genetic test

While the medical community continues to debate the benefits of CYP2D6 genetic testing for women on the breast cancer treatment tamoxifen, patients using the medication are anxious to have the tests. According to a new survey of more than 700 women with breast cancer currently taking tamoxifen, almost 80 percent of respondents would choose to have a genetic test that determines CYP2D6 genotype, yet only 14 percent of these women have been tested. CYP2D6 is an enzyme that influences how well the body processes tamoxifen into its more active form.

7 Dec 2010

Research roundup: Early retiree insurance; high deductible plans and skipped care; innovation and FDA

Health Care Use And Decision Making Among Lower-Income Families In High-Deductible Health Plans - This study examines the health care experiences of lower-income families (those with incomes that were less than 300% of the federal poverty level) with high-deductible health plans (HDHPs) compared to higher-income families.

7 Dec 2010

New endoscope aids in early detection and diagnosis of inflammatory bowel disease.

An international team of researchers led by the University of East Anglia (UEA) have developed a new kind of endoscope to aid the early detection and diagnosis of inflammatory bowel disease.

7 Dec 2010

Health experts, mobile service providers discuss potential for mobile health in Africa at summit

"Some 80 health professionals and telecom operators [met last week for the mHealth Africa Summit] in the Ghanaian capital Accra to explore ways to use mobile phones for better healthcare delivery," IRIN reports in an article that details a variety of successful projects relaying health information through cell phones in Africa. The article describes how mobile phones are being used in Africa to educate populations about HIV/AIDS, tuberculosis and improve maternal health, as well as to track medicines and other health supplies, including mosquito nets.

7 Dec 2010

GeoVax expands Phase 2a clinical trial for MVA62B HIV/AIDS vaccine

GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.

7 Dec 2010

New report reveals how African countries are performing in budgeting for their children

A new report launched today by The African Child Policy Forum (ACPF) measures African government’s investment in children and confirms that a country’s commitment to child rights and wellbeing is not dependent on their economic status, but rather on political will and spending priorities.

6 Dec 2010

Tapping young people's usage of online social networks could help control rise in HIV: Study

Tapping into young people's use of online social networks presents health agencies with a powerful opportunity to help control the rise in HIV and other sexually transmitted infections in homeless youth in Los Angeles. According to new research by Sean Young from UCLA and Eric Rice from USC in the US, online social networking - and the topics discussed on these networks - have the potential to affect sexual risk behaviors.

6 Dec 2010

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.

6 Dec 2010

HIV prevention programs worldwide are missing MSMs, survey finds

An online survey of men who have sex with men and their health service providers shows that the majority of respondents said most "gay men worldwide don't have access to HIV testing, counseling or free condoms and lubricant, a new study finds," according to a report by the Global Forum on MSM & HIV, HealthDay/Businessweek reports.

4 Dec 2010

The Female Health Company's fourth quarter unit sales increase 19% to 13.8 million

The Female Health Company, which manufactures and markets the FC2 Female Condom, today reported its financial results for the quarter and fiscal year ended September 30, 2010.

4 Dec 2010

HIV/AIDS opinions

"Promising scientific developments to prevent AIDS, not just treat its victims, have sparked hope among health officials, researchers and advocacy groups struggling to control the epidemic. Unfortunately, the global recession and soaring deficits in advanced nations have made it unlikely that sufficient money will be available to fully seize the new opportunities," according to a New York Times editorial, which postures, "[s]ome agonizing choices will have to be made."

4 Dec 2010

AIDS News and Research

Sound masking therapy is of uncertain benefit when used alone to treat tinnitus

WFP, UNAIDS work to improve nutritional support available for people living with HIV/AIDS

Opinions: Questioning WHO's relevance; Reforming foreign aid; Efforts to prevent child marriage

Genetic Immunity to present DermaVir and DermaPrep transdermal delivery system at HIV DART 2010 conference

USAID, PEPFAR and HHS welcome WHO's endorsement of rapid diagnostic test for TB

Rapid TB test endorsed by WHO

Vaccine World Summit to be held in New Delhi 1-3 March, 2011

European Commission must stop attacking generic medicines, says ITPC

Matrix's NDA for Abacavir Sulfate receives tentative FDA approval under PEPFAR

Breast cancer patients taking tamoxifen anxious to have CYP2D6 genetic test

Research roundup: Early retiree insurance; high deductible plans and skipped care; innovation and FDA

New endoscope aids in early detection and diagnosis of inflammatory bowel disease.

Health experts, mobile service providers discuss potential for mobile health in Africa at summit

GeoVax expands Phase 2a clinical trial for MVA62B HIV/AIDS vaccine

New report reveals how African countries are performing in budgeting for their children

Tapping young people's usage of online social networks could help control rise in HIV: Study

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

HIV prevention programs worldwide are missing MSMs, survey finds

The Female Health Company's fourth quarter unit sales increase 19% to 13.8 million

HIV/AIDS opinions

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News